Mega Genomics (HKSE:06667) PB Ratio : 3.36 (As of Jun. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Mega Genomics's share price is HK$9.98. Mega Genomics's Book Value per Share for the quarter that ended in Dec. 2023 was HK$2.97. Hence, Mega Genomics's PB Ratio of today is 3.36.

The historical rank and industry rank for Mega Genomics's PB Ratio or its related term are showing as below:

HKSE:06667' s PB Ratio Range Over the Past 10 Years
Min: 2.7 Med: 3.55 Max: 5.07
Current: 3.36

During the past 5 years, Mega Genomics's highest PB Ratio was 5.07. The lowest was 2.70. And the median was 3.55.

HKSE:06667's PB Ratio is ranked worse than
72.41% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.07 vs HKSE:06667: 3.36

During the past 12 months, Mega Genomics's average Book Value Per Share Growth Rate was 2.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 50.30% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Mega Genomics was 50.30% per year. The lowest was 50.30% per year. And the median was 50.30% per year.

Back to Basics: PB Ratio

Mega Genomics PB Ratio Historical Data

The historical data trend for Mega Genomics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics PB Ratio Chart

Mega Genomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

4.51

3.47

Mega Genomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial			-	5.60	4.51	3.41	3.47

Competitive Comparison of Mega Genomics's PB Ratio

For the Diagnostics & Research subindustry, Mega Genomics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Genomics's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mega Genomics's PB Ratio falls into.

Mega Genomics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Mega Genomics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	9.98	/	2.966
	=	3.36

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Mega Genomics (HKSE:06667) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Mega Genomics PB Ratio Related Terms

Thank you for viewing the detailed overview of Mega Genomics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Genomics (HKSE:06667) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

North Garden Road, 401 Health Work, Haidian District, Beijing, CHN

Website

https://www.megagenomics.cn

Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.

Executives

Guo Meiling	2101 Beneficial owner
Lin Lin	2101 Beneficial owner
Yu Rong	2501 Other
Infinite Galaxy Health Limited	2101 Beneficial owner
Mei Nian Investment Limited	2101 Beneficial owner
Kastle Limited	2501 Other
Mega Marvelous Limited	2501 Other
Yurong Technology Limited	2101 Beneficial owner
Niu Zhencai	2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si	2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

Mega Genomics (HKSE:06667) Headlines

No Headlines